Experian announces death of CFO
Experian's Chief Financial Officer (CFO) Paul Brooks has passed away, the credit-checking and information services firm revealed on Monday.
Experian's Chief Financial Officer (CFO) Paul Brooks has passed away, the credit-checking and information services firm revealed on Monday.
According to Experian's statement, Brooks, who joined the group as Finance Director of its former International division back in 1999, died suddenly over the weekend at his home in California.
"Paul was a great friend, a talented colleague and an inspirational leader and will be greatly missed by all those who had the pleasure of working and dealing with him," said Chairman Sir John Peace.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
"Our immediate thoughts are with his wife and family and we will do everything we can to support them at this difficult time," Peace added.
Brooks was also a non-executive director at FTSE 100 outsourcing giant Serco, whose Chairman Alastair Lyons said this morning - "Paul joined the Serco Group board just one year ago and immediately became a much valued colleague. He will be greatly missed by all of us and our sincerest condolences are with Paul's family."
BC
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
Energy bills to rise by 1.2% in January 2025
Energy bills are set to rise 1.2% in the New Year when the latest energy price cap comes into play, Ofgem has confirmed
By Dan McEvoy Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published